Moreover, the WB results showed that the protein expression of IL-1β and TNF-α was increased in the DM group, while the increase in the expression of IL-1β and TNF-α was inhibited by IL-22BP administration (P < 0.01; Fig. 5e–g). This evidence concerns the gene IL22RA2 and diabetes mellitus.